Clinical Trials in Chicago

Showing 11021-11040 of 20,493 trials

Phase 2/3 Study of IGSC, 20% in PIDD

NCT01218438

The purpose of this study is to develop a 20% subcutaneous (SC) immunoglobulin preparation for the treatment of patients with primary immunodeficiency diseases (PIDD).

Primary Immunodeficiency Diseases (PID)

Baxalta now part of Shire86 participantsStarted Jan 2013

Irvine, California, United States • Centennial, Colorado, United States • North Palm Beach, Florida, United States +15 more locations

TERMINATEDPhase 22.2 miles

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

NCT03756285

A randomized, double-blind, placebo-controlled, parallel group, multicentre study in patients with Heart Failure with preserved Ejection Fraction (HFpEF). The study will be conducted at approximately 15 sites in 5 countries. Approximately 96 patients will be randomized to AZD4831 or placebo (treatment duration 90 days).

Heart Failure

AstraZeneca41 participantsStarted Dec 2018

Chicago, Illinois, United States • Boston, Massachusetts, United States • Aarhus N, Denmark +10 more locations

Phase 2/3 Study of IGSC, 20% in PIDD

Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.

Find Trials by Condition in Chicago

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload

Effect of Body Position and Probe Position on the Localization of Breast Mass

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel

A Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Study of Cryoablation for Metastatic Lung Tumors

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Safety Study for Beta Thalassemia Subjects on PTG-300

Breast Mesh Used in Two-staged Breast Reconstruction